Dilaudid can be used to break through Bupe. In most cases of serious trauma, bupe patients may receive fentanyl. It is very risky, so it is seldom done.
For individuals who take a low dose (<8mg) and do not dose regularly, it would be much easier to "break through." For people who take more than 8mg or take it daily, the necessary dose may be higher and they would need to be put on a pump until the bupe in their body is mostly metabolized.
Most of the buprenorphine that you take becomes bound to blood proteins and is inactive. Only the unbound portion can cross the BBB and activate receptors. It is mostly unbound after ingestion, and then becomes bound and is slowly release over the course of several days. In this way, a BMT patient may titrate small amounts of bupe from their protein-drug reserves in their blood. Hydromorphone is short acting, so whether it wears off or is forced off by bupe is hard to say. If one is able to break through with a longer acting opioid, the effects would be short-lived because of the unbinding of bupe. For these patients, a PCA pump with or without a continuous rate may be necessary. The problem becomes more complex with high dose BMT patients, because the level needed to break through can be very close or even higher than the lethal dose.
For individuals who take a low dose (<8mg) and do not dose regularly, it would be much easier to "break through." For people who take more than 8mg or take it daily, the necessary dose may be higher and they would need to be put on a pump until the bupe in their body is mostly metabolized.
Most of the buprenorphine that you take becomes bound to blood proteins and is inactive. Only the unbound portion can cross the BBB and activate receptors. It is mostly unbound after ingestion, and then becomes bound and is slowly release over the course of several days. In this way, a BMT patient may titrate small amounts of bupe from their protein-drug reserves in their blood. Hydromorphone is short acting, so whether it wears off or is forced off by bupe is hard to say. If one is able to break through with a longer acting opioid, the effects would be short-lived because of the unbinding of bupe. For these patients, a PCA pump with or without a continuous rate may be necessary. The problem becomes more complex with high dose BMT patients, because the level needed to break through can be very close or even higher than the lethal dose.